Up to the minute news about Healthcare management. We'll find the latest Nursing news so you can chat about here.
Post your comments about this story here.
Medtronic Inc. announced Wednesday that the U.S. Food and Drug Administration has approved two of the company's cardiac rhythm disease management products. The Concerto cardiac resynchronization therapy-defibrillator (CRT-D) and Virtuoso implantable
Thu, 18 May 2006 01:00:00 GMT
Post your comments about this story here.